Coupling transcriptional and post-transcriptional miRNA regulation

































miRNAs are key regulators of cell fate 
 
miRNAs have emerged in the past decade as important 
players in numerous cellular and organismal processes 
in animals and plants [1]. Deletion of the Dicer gene, 
encoding the critical enzyme involved in miRNA 
processing and maturation, is embryonic lethal in both 
mice [2] and zebrafish [3]. Accordingly, many studies 
showed, using conditional elimination of Dicer, that 
miRNAs are crucial for the proper spatiotemporal 
development of various tissues and organs ([2, 4-9] and 
reviewed in [10]). Further, mouse embryonic stem (ES) 
cells defective in miRNA processing were shown to 
proliferate slower [11], and to be impaired in their 
ability to differentiate [8]. In parallel, other studies have 
shown a major role for miRNAs in development, 
indicating that many miRNAs are upregulated during 
the process of ES cell differentiation ([12] and reviewed 
in [13]). Many miRNAs also play a role in 
differentiation processes in the adult organism, 



































response [15]. In fact, the first miRNAs to be 
discovered,  lin-4  and  let-7  in  c.elegans, regulate 
epithelial cell differentiation [16, 17]. In addition, 
manipulations of individual miRNA genes were shown 
to result in marked defects at the organismal level ([18, 
19] and reviewed in [20]). Based on these accumulated 
observations it is plausible to suggest that in many cases 
miRNAs are indeed a part of the driving force of 
differentiation processes. miRNAs were also shown to 
regulate many cellular processes [21, 22] , such as cell 
growth and proliferation (reviewed in [23, 24]) and 
apoptosis (reviewed in [25]). It appears, therefore, that 
miRNAs are crucial players in the regulation and 
determination of cell fate. 
 
miRNAs – guardians of genome integrity? 
 
Lu et al.  [26] carried out an extensive analysis of 
miRNA expression in human cancer. This study, that 
included a global expression profiling of miRNAs 
across a large set of tumors, demonstrated that miRNA 
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cancers of unknown origin. In addition, the researchers 
made the very interesting observation that, in general, 
tumors have lower levels of miRNAs than normal 
tissues. The authors suggested that the observed low 
global levels of miRNAs may be a reflection of the de-
differentiated state of tumors. 
 
An alternative, complementary explanation might be 
that tumors evolve to silence the miRNA pathway 
during the course of cancer progression. In other words, 
globally avoiding regulation of gene expression by 
miRNAs may be one of the many ways of cancer cells 
to enhance their proliferation and tumorigenic potential. 
 
Several lines of evidence support the idea that 
proliferating cells and cancer cells in particular, find 
many different ways to avoid post-transcriptional 
regulation by miRNAs (Figure 1). Some of these 
mechanisms are straightforward, and are in agreement 
with what we know of tumor suppressors and 
oncogenes. For example, the MYC  oncogenic 
transcription factor (TF) was found in a lymphoma 
mouse model to mediate widespread repression of a 
large set of miRNAs, contributing to tumorigenesis 
[27]. Other mechanistic possibilities for tumors to avoid 
posttranscriptional regulation by miRNAs include 
epigenetic silencing, mutation and deletion of genomic 
loci encoding for miRNAs [28-33]. A prominent 
example is the miR-15a/16-1  cluster, residing in the 
DLEU2 non-coding RNA, which was long known to be 
frequently deleted in leukemia [34, 35], and was later 
shown to harbor these miRNAs [29]. Another newly 
described mechanism is the interruption of the miRNA 
biogenesis pathway, by processes such as nuclear 
retention of unprocessed pre-miRNAs [36], or pri- and 
pre-miRNA processing blockage such as in the case of 
inhibition of maturation of the let-7 family by the Lin28 
protein [37-39]. Lin28  was further shown to promote 
cancer, and this was attributed to its repression of the 
let-7  miRNA family [40]. A recent report implicates 
p53 in the enhancement of miRNA maturation for many 
miRNAs following DNA damage [41], attesting to 
global miRNA upregulation as a possible anti-cancer 
mechanism. Additional highly intriguing phenomenon 
was reported by Sandberg et al.  [42], indicating that 
proliferating cells tend to employ alternative 
polyadenylation or alternative splicing in order to 
express mRNAs with shorter 3’ UTRs, having fewer 
miRNA binding sites. These shorter mRNAs avoid 
post-transcriptional regulation by miRNAs, thus 
potentially enhancing their protein level. This 
phenomenon represents another path by which 
proliferating cells achieve the same goal – avoiding 
miRNA-mediated silencing, presumably in order to 
accelerate proliferation. 
 
The most striking evidence in support of the 'miRNA 
avoidance' strategy played by tumors is shown by two 
seemingly contradictory studies, one focusing on cancer 
cells and the other on normal cells. The study by Kumar 
et al.  [43] reported that the ablation of miRNAs in 
various cancer cell lines resulted in enhanced cellular 
transformation, evident by increased colony formation 
efficiency in vitro and increased tumor burden in vivo. 
On the other hand, Mudhasani et al. [44] showed that 
the total elimination of miRNAs using conditional 
Dicer  knock-out results in premature senescence in 
normal mouse embryonic fibroblasts (MEFs). This 
effect was also apparent at the level of the organism, as 
the knock-out of Dicer  in keratinocytes and skin 
epidermis of adult mice resulted in senescence-induced 
hairloss and skin aging [44]. 
 
At first glance, these two studies seem to disagree. How 
is it possible that a similar manipulation would enhance 
proliferation in one system, and cause a proliferation 
arrest or senescence in the other? A potential solution to 
this conflict would consider that the same event can 
lead to two opposite outcomes, depending on the 
cellular context. For example, activation of an 
oncogene, such as RAS, is one of the hallmarks of 
cancer, and when occurring in cancer cells will cause 
the enhancement of their tumorigenic phenotype. 
However, in normal cells, oncogene activation will 
often lead to genomic instability, which is sensed by the 
DNA damage checkpoint, and leads to p53 and ARF-
dependent senescence, a phenomenon known as 
"oncogene-induced senescence" [45]. Importantly, the 
phenomenon described by Mudhasani et al.  [44] was 
not a classical case of oncogene-induced senescence, as 
it was not accompanied by the upregulation of the 
oncogenes MYC or RAS, (two well known activators of 
oncogene-induced senescence), even though they are 
documented miRNA targets [46-48]. Interestingly, 
however, the depletion of miRNAs led to DNA damage, 
as evident by γH2A.X  staining, and consequently, 
through activation of the p19ARF  and  p53-dependent 
DNA-damage checkpoint, resulted in premature 
senescence. 
 
Therefore, in this case too, the same event of global 
miRNA depletion induced the DNA damage checkpoint 
in normal cells due to proper p19ARF  and  p53 
activation, while in cancer cells it led to enhanced 
transformation, where these checkpoint response 
pathways are frequently inactivated, and genomic 












































Importantly, as we outline here, inactivation of miRNA-
mediated silencing is not only capable in principle of 
influencing cell fate, following genetic manipulations as 
shown by Mudhasani et al. and Kumar et al. [43, 44], 
but may actually occur in vivo during tumorigenesis 
[26, 42]. It therefore seems likely that miRNAs are not 
only necessary for proliferation and differentiation in 
normal cells, but also act to maintain normal cell prolife-
ration, and may be thought of as “guardians” of genome 
integrity. In cancer cells, on the other hand, inactivation 
of the miRNA-mediated silencing pathway and the 
avoidance of miRNA regulation contribute to transforma-
tion (Figure 1). In principle we can therefore consider 
miRNAs as a regulatory barrier whose removal may be 
















































A conceptual gap between the influence of miRNAs 
on protein levels and their effects on cell fate 
 
miRNAs can exert their silencing effects by cleavage of 
their target mRNAs and by inhibition of their 
translation. A common knowledge in the field was that 
animal miRNAs exert most of their silencing through 
the inhibition of translation, rather than through the 
degradation of their targets, and that this was due to a 
low overall degree of sequence complementarity that 
animal miRNAs share with their target sites on 3’ UTRs 
of mRNAs [1]. In fact, the first discovered miRNAs in 
C. elegans, lin-4, was shown to inhibit the translation of 
its target Lin-14, without affecting its mRNA levels [50, 
51]. Mechanistically, it became evident that the 
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enzymatically capable of both mRNA cleavage and 
inhibition of translation [52, 53]. Lim et al. then showed 
that miRNAs can influence the mRNA levels of their 
target genes [54]. Using overexpression of miRNAs 
followed by global expression profiling using 
microarrays, they demonstrated a modest but significant 
downregulation of mRNA levels of genes that were 
enriched for the miRNA seed sequence. This study and 
others that followed contributed to the overall view that 
miRNAs exert silencing through both mechanisms 
simultaneously, but the more major effect was expected 
at the protein level, rather than at the mRNA levels. 
 
Recent studies used high throughput proteomics in 
order to both identify translationally inhibited targets 
and to more accurately assess the extent of inhibition 
that a miRNA exerts on mRNA levels and on protein 
levels [55, 56]. These studies reported that individual 
miRNAs affect hundreds of proteins in the human and 
mouse out of thousands that were examined. However, 
the levels of these proteins were decreased only to a 
relatively mild extent. miRNAs were often before 
considered as modulators of expression, and their 
generally observed mild effect on protein levels (and 
mRNA levels as well) promoted their suggested role as 
buffers for noise in protein expression, which may 
confer robustness to developmental programs [57]. 
 
Overall, there seems to be a discrepancy between the 
observation that miRNAs have such subtle effects on 
protein levels and the fact that their effects on cell fate 
are so profound. We would like to suggest here one 
possible model that might bridge this conceptual gap. 
 
Coupling transcriptional and post-transcriptional 
miRNA regulation in the control of cell fate 
 
One trivial way to resolve the above discrepancy might 
argue that the multiplicity of miRNA targets and the 
simultaneous down-regulation of many proteins might 
have a cumulative effect, eventually exerting a 
significant impact on cell fate, even though individual 
proteins are repressed to a very modest extent. This is a 
valid argument, particularly since some miRNAs were 
predicted and shown to have multiple targets within the 
same pathway [58-60], thus potentially having greater 
effects on entire pathways than on individual proteins. 
 
While miRNAs may exert modest effects, yet on many 
targets, another possible answer to their significant 
effect on cell fate may lie in the level of the regulatory 
networks that miRNAs take central part in. miRNAs do 
not act in isolation, but rather they regulate target genes 
combinatorially with one another, and are often 
embedded within intricate regulatory networks together 
with TFs (Figure 2). In fact, it was demonstrated that at 
the network level, there is tight coupling between 
posttranscriptional regulation by miRNAs and the 
regulation of transcription by TFs [61, 62]. Examination 
of regulatory networks showed that in many cases the 
same TF controls the transcription of both a miRNA 
and the targets of that miRNA, or is regulated by the 
same miRNA with which it shares common targets, 
forming a diversity of combined transcriptional/post-
transcriptional Feed-Forward Loops (FFLs). 
Collectively, such FFLs potentially regulate thousands 
of target genes. 
 
Network analyses showed that these FFLs constitute 
over-represented architectures in the mammalian 
regulatory network [61, 62]. Network FFLs, initially 
described by Alon and colleagues, were shown to 
comprise a major component of the transcription 
networks in bacteria and yeast [63, 64]. The discovery 
that miRNAs and TFs also constitute FFLs offered new 
possibilities for potential functions for these regulatory 
units. Clues for the existence of coupling between 
transcription and miRNA regulation emerged from a 
very intriguing concept, called miRNA-target 
avoidance. Two parallel studies, one in Drosophila and 
the other in mammals, showed that during development 
as well as in adult tissues, miRNA targets often avoid 
being expressed in the same tissue, or at the same 
developmental time, as their potential inhibitory 
miRNA [65, 66]. In Drosophila, it was shown for some 
cases that a miRNA and its targets are expressed in 
adjacent tissues during development, or in consecutive 
developmental stages, and that miRNAs serve as key 
players in the precise definition of spatiotemporal 
differentiation boundaries [66]. This phenomenon was 
observed also in adult tissues and organs in both 
Drosophila  [66] and mouse [65]. Moreover, both 
studies indicated that this mutual exclusion of miRNAs 
and their targets does not stem from target degradation 
by the miRNA. From these two studies, it became 
evident that posttranscriptional regulation by miRNAs 
is somehow coordinated with transcription. However, it 
was not shown originally how, at the mechanistic level, 
such "miRNA-target spatiotemporal avoidance" is 
achieved. Combined transcriptional/posttranscriptional 
FFLs, where the same TF regulates the transcription of 
both a miRNA and its target genes, or where the 
miRNA targets a TF and its target genes as well, could 
serve just that purpose (Figure 3). Such FFLs are thus 
suggested as a simple mechanism that might facilitate 
the miRNA-target avoidance phenomenon, where a TF 
that activates the target genes also represses the miRNA 
transcription in the tissues in which it is expressed, or 
the miRNA represses both the TF and its target genes, 
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targets in the tissue where it is expressed (Figure 3) 
[61]. In addition, such FFLs were further suggested to 
enable the "canalization" and the maintenance of 
fidelity of developmental processes in general [57]. 
 
More recently, evidence has been accumulating that 
such combined transcriptional post-transcriptional FFLs 
indeed act as functional units in the regulation of cell 
fate in many cell types and systems [48, 58, 67-71]. One 
striking example, recently published by Marson et al. 
[69], demonstrated that miRNAs and TFs are involved 
together in FFLs controlling the maintenance of mouse 
embryonic stem (ES) cell identity. Consistent with the 
studies mentioned above [2, 3, 8, 11], which showed 
that complete miRNA ablation from ES cells eliminates 
their differentiation capacity, Marson et al. showed that 
several FFLs involving miRNAs and ES cell TFs act to 
regulate ES cell identity and differentiation. For 
example, the miR-290-295  polycistronic cluster, 
containing the most abundantly expressed miRNAs in 
mouse ES cells, is positively regulated by the ES cell 
TF Oct4, whereas its promoter is co-occupied by Oct4, 
Sox2, and Nanog. In addition, miR-290-295 co-regulate 
mutual target genes along with these same TFs. 
Intriguingly, while miR-290-295  is a rodent specific 
cluster, a similar FFL involving Sox  and  Oct4  was 
computationally predicted in humans [61]. This FFL 
comprises miR-302, which shares the same seed as the 
rodent-specific  miR-290-295, and was shown to be 
highly expressed in human ES cells [72], perhaps 
serving as a miR-290-295  human ortholog. 
Consideration of these results in the perspective of 
previous studies on miRNAs role in ES cell 




















volving FFLs might play an important role in this 
context, and suggest potential conserved roles for 
similar FFLs in the maintenance of human ES cell 
identity as well. 
 
A different perspective on miRNA-TF FFLs was recently 
provided by Brosh et al. [58]. In this study, a family of 15 
homologous miRNAs transcribed as three polycistrons: 
miR-106b/93/-25, miR-17-92 and miR-106a-363, were 
shown to form a proliferation-promoting FFL together 
with the transcription factor E2F. These miRNAs were 
shown to target a whole battery of anti-proliferative E2F 
target genes. Most importantly, the study demonstrated 
that in normal fibroblasts p53 inhibits this FFL as a 
central step towards cellular senescence. When this 
inhibition is perturbed by overexpression of the miRNAs, 
normal cell fate is altered; proliferation is accelerated and 
senescence is delayed. In agreement with these results, 
breast cancer tumors bearing mutated p53 showed an 
elevation in the levels of these miRNAs and were 
characterized by a high tumor grade, hinting at the role of 
these miRNAs in promoting proliferation and 
aggressiveness also in vivo in tumors. This miRNA 
family was indeed reported in several independent 
studies to be related to promotion of cancer [58, 73, 74] 
(also reviewed in [75]). The above study illustrates how 
deregulation of the entire FFL may contribute to 
aberrant proliferation. It also reveals another concept of 
network wiring of miRNAs, namely combinatorial 
regulation, and more specifically combinatorial 
regulation by family-related miRNAs (Figure 2). 
Combinatorial regulation by miRNAs was globally 
predicted based on co-occurrence of miRNA target sites 
in common gene sets [61], and was also observed 














































































miRNAs can be grouped by mature sequence similarity 
into miRNA families. In some cases, as in the case of 
the  miR-106b/93/-25  family mentioned above, these 
families are shown to represent paralogous groups of 
miRNAs of a common evolutionary origin [77]. Just as 
paralogous genes were duplicated during evolution but 
retained some degree of sequence similarity, these 
paralogous miRNAs share similarity in their sequence, 
which immediately suggests that they might also share 
common target genes. More intriguingly, it seems that 
in many cases such families had not only retained 
similar targets, but also retained similar transcriptional 
programs. As described by Brosh et al. [58], the above 
family of 15 miRNAs retained their joint transcriptional 
regulation by E2F. Coordinated transcriptional 
regulation of a family of miRNAs, sharing similar 
targets, all of which are part of the same pathway (in 
this case negative regulators of proliferation), may have 
a cumulative effect on the overall levels of proteins in 
the pathway, thus resulting in a strong effect on cell 
fate. 
 
Coordinated regulation of family miRNAs was also 
shown in other cases [78, 79]. For example the miR-34 
family, consisting of two transcription units and three 
mature family members, were all shown to be 
transcriptionally activated by p53 and to contribute to 
apoptosis [80, 81], G1 cell-cycle arrest [82] and 
senescence [83]. Moreover, miR-34a and miR-34c were 
shown to target c-MYC [46, 84]. In addition, in both 
mouse and human ES cells, several related miRNA 
families, often sharing similar seeds, were shown to be 
co-expressed [69, 72]. Moreover, miRNAs from the 
same family were indeed verified experimentally to 
have many shared targets [76]. 
Figure 3. Possible roles for FFLs of miRNAs, Transcription
Factors  (TFs)  and  their  mutual  targets  in  facilitating
spatiotemporal avoidance, or noise buffering. miRNAs are
often embedded in Feed‐Forward loops (FFLs) with TFs, sharing




figure  depicts  how  the  network  wiring  of  miRNAs  in  combined
transcriptional/posttranscriptional  FFLs  may  explain  the  spatio‐






correlates  across  tissues.  (B)  Temporal  avoidance  may  be
facilitated by the presented FFL when a miRNA and a TF are co‐
expressed  in  the  same  tissues,  creating  a  temporal  shut‐down
mechanism  for  their  mutual  targets,  when  there  is  a  delay
between the activation of the targets by the TF, and its activation
of the miRNA. This delay may be achieved for example by a lower
affinity  binding  site  of  the  TF  to  the  miRNA's  promoter,  by  a




Overall it seems that combinatorial regulation of 
miRNAs, particularly from the same family, and shared 
transcription programs for such miRNAs and their 
common targets portray intricate network architecture 
(Figure 2). Such architecture is not only over-
represented [61], but may also cumulatively generate a 
strong output that is likely to account for the observed 
effects on cell fate, and for its alteration when the 




It is intriguing that despite a relatively mild influence of 
individual miRNAs on protein levels they are indis-
pensable to various cellular and organismal processes, 
including control of cell fate and maintenance of 
genomic integrity. One possible explanation for this 
may lie in the level of regulatory networks in which 
miRNAs are embedded. Indeed, joint miRNA-TF FFLs 
are not only an over-represented architecture in the 
network but a recurring principle of miRNA regulation 
of cell fate. 
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miRNAs in coupled transcription/post-transcriptional 
networks is appealing, and the multiple evidence 
outlines here serve to support it. 
 
Two principles are common to the different examples 
discussed above: 
1. miRNAs are embedded in combined transcription-
nal/post-transcriptional FFLs that co-target many genes.  
2. Several co-regulated miRNAs act together to exert 
their regulation on target genes involved in the same 
pathway.  
However, more studies should be undertaken in order to 
fully establish the link between the network wiring of 
miRNAs in transcriptional/post-transcriptional FFLs 
and their effect on cell fate. A recent study 
demonstrated that the wiring of miR-7 in a network of 
FFLs in the fly equips the network with robustness to 
environmental perturbation [68]. Such approach 
suggests that when studying possible roles for miRNAs, 
one should consider them as parts of a larger regulatory 
network, rather than adopting the reductionist view of 
single miRNA – single target. Our recognition of the 
centrality of miRNAs in the regulatory network may 
help us to elucidate how miRNAs exert such profound 
impact on cell fate. 
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